世界の治療薬モニタリング市場の規模は2023年に18億ドルと評価され、2024年から2030年にかけて3.8%のCAGRで成長すると予測されます。市場の主な推進要因には、遺伝子検査の需要の増加、診断の技術的進歩、治療薬モニタリングに起因する研究実験、患者数の増加、薬物モニタリングの使用に関する政府の支援的な規制と政策などがあります。例えば、2019年8月、米国FDAは、肺XDR、治療不耐性または非反応性MDR結核、およびプレトマニド200mgとベダキリンの併用を成人のリネゾリド (BPaL) に承認しました。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Therapeutic Drug Monitoring Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Therapeutic Drug Monitoring Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Therapeutic Drug Monitoring Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Therapeutic Drug Monitoring Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Equipment
4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Immunoassay Analyzers
4.3.2.1. Immunoassay Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Clinical Chemistry Analyzers
4.3.3.1. Clinical Chemistry Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Chromatography & MS detectors
4.3.4.1. Chromatography & MS detectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Consumables
4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Therapeutic Drug Monitoring Market: Drug Class Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Therapeutic Drug Monitoring Market: Drug Class Movement Analysis, 2024 & 2030 (USD Million)
5.3. Antiarrhythmic Drugs
5.3.1. Antiarrhythmic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Immunosuppressants
5.4.1. Immunosuppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Antiepileptic Drugs
5.5.1. Antiepileptic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Therapeutic Drug Monitoring Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Therapeutic Drug Monitoring Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnostic Centers
6.4.1. Diagnostics Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Therapeutic Drug Monitoring Market: Regional Estimates & Trend Analysis
7.1. Therapeutic Drug Monitoring Market Share, By Region, 2024 & 2030 (USD Million)
7.2. North America
7.2.1. North America Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. China Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Australia Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. South Korea Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Abbott
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. ALPCO
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Beckman Coulter, Inc
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Bio-Rad Laboratories, Inc.
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Thermo Fisher Scientific Inc.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Chromsystems Instruments & Chemicals GmbH
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. F.Hoffmann-La Roche Ltd.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Randox laboratories Ltd
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Siemens Healthineers AG.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. biomérieux, Inc.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
